Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
This JAMA Insights Clinical Update reviews lipid-lowering therapies prescribed to reduce cardiovascular risk, including statins and ezetimibe, as well as novel therapies such as PCSK-9 inhibitors, bempedoic acid, icosapent ethyl, and inclisiran.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | General Medicine | Heart | Statin Therapy | Vytorin | Zetia